MedPath

A randomized controlled trial comparing conventional ESD versus hybrid ESD for gastric neoplasms

Not Applicable
Conditions
Gastric neoplasm
Registration Number
JPRN-UMIN000041244
Lead Sponsor
Graduate School of Medicine, Kyushu University
Brief Summary

The procedure time of H-ESD was significantly shorter than that of C-ESD (33.16 min vs 62.46 min; H-ESD/C-ESD ratio: 0.53; 95% confidence interval, 0.41-0.69; P < .0001).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
82
Inclusion Criteria

Not provided

Exclusion Criteria

-Patients with a history of gastric surgery -Patients on dialysis -Patients requiring continuous administration of heparin during perioperative period. -Contraindication with endoscopy; ileus, gastrointestinal perforation or severe respiratory/cardiac disease. -Metal allergy -Patients who are judged inappropriate by physician participating in this trial -Patients who cannot obtain informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Procedure time of ESD
Secondary Outcome Measures
NameTimeMethod
Time and speed of mucosal incision Time and speed of submucosal dissection with or without snaring En bloc and complete resection Curability judged by histological assessment of resected specimen Endoscopic procedural adverse events including intraoperative perforation, delayed perforation and delayed bleeding Degree of dissected submucosal layer before snaring Volume of injective solution Number and time of hemostasis using hemostatic device during procedure Thickness of submucosal layer in resected specimen The relationship between outcomes and morphology / location / size/ ulceration / operator's experience.
© Copyright 2025. All Rights Reserved by MedPath